Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


1 Ann Rheum Dis
3 Arthritis Res Ther
12 Clin Rheumatol
1 J Immunol
10 J Rheumatol
1 Z Rheumatol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Rheum Dis

  1. STUDENIC P, Felson DT, de Wit M, Smolen JS, et al
    Response to: 'Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis' by Bugatti et al.
    Ann Rheum Dis. 2022;81:e56.

    Arthritis Res Ther

  2. VITTECOQ O, Guillou C, Hardouin J, Gerard B, et al
    Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination.
    Arthritis Res Ther. 2022;24:72.
    PubMed         Abstract available

  3. KONDO F, Sugihara T, Umezawa N, Hasegawa H, et al
    Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.
    Arthritis Res Ther. 2022;24:92.
    PubMed         Abstract available

  4. DE ARMAS-RILLO L, Quevedo-Abeledo JC, Hernandez-Hernandez V, de Vera-Gonzalez A, et al
    The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2022;24:99.
    PubMed         Abstract available

    Clin Rheumatol

  5. POGGENBORG RP, Madsen OR, Sweeney AT, Dreyer L, et al
    Correction to: Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trial.
    Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06193.

  6. CHU Y, Xu S
    Rebuttal letter referring to the article "Synergy of sarcopaenia and vitamin D deficiency in vertebral osteoporotic fractures in rheumatoid arthritis".
    Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06188.

  7. KARA M, Ozcakar L
    Synergy or a third (causative) factor for fractures in rheumatoid arthritis?
    Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06173.

  8. YAYLA ME, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer AB, et al
    Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey.
    Clin Rheumatol. 2022;41:1457-1463.
    PubMed         Abstract available

  9. PADIYAR S, Kamath N, Mathew J, Chandu AS, et al
    New-onset Adult-onset Still's disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature.
    Clin Rheumatol. 2022;41:1569-1575.
    PubMed         Abstract available

  10. KATZ G, Ogdie A, Baker JF, George MD, et al
    Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis.
    Clin Rheumatol. 2022;41:1323-1331.
    PubMed         Abstract available

  11. ANDERS B, Anders M, Kreuzer M, Zinn S, et al
    Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis.
    Clin Rheumatol. 2022 Apr 30. pii: 10.1007/s10067-022-06185.
    PubMed         Abstract available

  12. ROONGTA R, Mondal S, Haldar S, Kumar MS, et al
    Two flares of Still's disease after two doses of the ChAdOx1 vaccine.
    Clin Rheumatol. 2022;41:1591-1596.
    PubMed         Abstract available

  13. KIM JW, Jung JY, Suh CH, Kim HA, et al
    Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature.
    Clin Rheumatol. 2022;41:1583-1589.
    PubMed         Abstract available

  14. SAHOO RR, Wakhlu A, Agarwal V
    Neglected tropical rheumatic diseases.
    Clin Rheumatol. 2022;41:1293-1304.
    PubMed         Abstract available

  15. LV X, Zhou M, Zhang Q, He Y, et al
    Abnormal Histones Acetylation in Patients with Primary Sjogren's Syndrome.
    Clin Rheumatol. 2022;41:1465-1472.
    PubMed         Abstract available

  16. VEGA-MORALES D, Del Carmen Larios-Forte M, Perez-Barbosa L, Esquivel-Valerio JA, et al
    Bone erosions by MRI in first-degree relatives of patients with RA: an exploratory study.
    Clin Rheumatol. 2022;41:1343-1348.
    PubMed         Abstract available

    J Immunol

  17. BANDA NK, Deane KD, Bemis EA, Strickland C, et al
    Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.
    J Immunol. 2022 May 2. pii: jimmunol.2101170. doi: 10.4049/jimmunol.2101170.
    PubMed         Abstract available

    J Rheumatol

  18. CAGNOTTO G, Jacobsson THL, Rydell E, Eberhard A, et al
    Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
    J Rheumatol. 2022 May 2. pii: jrheum.211199. doi: 10.3899/jrheum.211199.
    PubMed         Abstract available

  19. DIRENZO DD, Robinson S, Bingham CO 3rd, Baer AN, et al
    PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjogren Syndrome.
    J Rheumatol. 2022;49:470-474.
    PubMed         Abstract available

  20. EDER L, Croxford R, Drucker AM, Mendel A, et al
    COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    J Rheumatol. 2022;49:523-530.
    PubMed         Abstract available

  21. WIDDIFIELD J, Eder L, Chen S, Kwong JC, et al
    COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    J Rheumatol. 2022;49:531-536.
    PubMed         Abstract available

  22. DE ANGELIS R, Giuggioli D, Bajocchi G, Dagna L, et al
    Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
    J Rheumatol. 2022;49:176-185.
    PubMed         Abstract available

  23. KREMER JM, Reed G, Pappas DA, Kane K, et al
    Dr. Kremer et al reply.
    J Rheumatol. 2022;49:338-339.

  24. BERARDICURTI O, Pavlych V, Cola ID, Ruscitti P, et al
    Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center.
    J Rheumatol. 2022;49:171-175.
    PubMed         Abstract available

  25. KAWADA T
    Smoking, Obesity, and Risk of Primary Sjogren Syndrome.
    J Rheumatol. 2022;49:234.

  26. BERTI A, Cornec D, Crowson CS, Matteson EL, et al
    Dr. Berti et al reply.
    J Rheumatol. 2022;49:234.

  27. GRIFFITHS H, Smith T, Mack C, Leadbetter J, et al
    Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset.
    J Rheumatol. 2022;49:150-156.
    PubMed         Abstract available

    Z Rheumatol

  28. ZHANG G, Liu W, Zhang X, Liu L, et al
    Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
    Z Rheumatol. 2022;81:335-338.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.